Amgen’s new $200M next-gen biologic plant a first in U.S.

R.I. EXPANSION: Rohan Persaud, plant manager and executive director at Amgen Rhode Island, stands outside the company’s new next-generation biomanufacturing plant in West Greenwich. He is overseeing the startup and licensing of the facility.  / PBN PHOTO/ELIZABETH GRAHAM
R.I. EXPANSION: Rohan Persaud, plant manager and executive director at Amgen Rhode Island, stands outside the company’s new next-generation biomanufacturing plant in West Greenwich. He is overseeing the startup and licensing of the facility. / PBN PHOTO/ELIZABETH GRAHAM
The cargo that arrived in 2019 at the Port of Davisville in North Kingstown from overseas was something that had never been shipped to the United States: Three shiploads of modular pieces and parts that when fully assembled would create a state-of-the-art “next-generation” biomanufacturing factory. The 120,000-square-foot structure had been mostly constructed in Shanghai, then…

You must be a subscriber to read this content. To keep reading and receive unlimited access subscribe today. Hurry, in honor of our 35th anniversary, you can get 35% off a one-year print + digital subscription.
Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display